Effect of Pfizer/BioNTech and Sinovac/CoronaVac Vaccines on Semen Parameters in Infertile Patients with Idiopathic Infertility: A Single-center Cohort Study

Effect of Pfizer/BioNTech and Sinovac/CoronaVac Vaccines on Semen Parameters in Infertile Patients with Idiopathic Infertility: A Single-center Cohort Study

Objective:We investigated the effects of Coronavirus disease-2019 (COVID-19) vaccines on semen parameters in patients with idiopathic infertility who visited our urology clinic.Materials and Methods:Patients who visited our andrology clinic between January 2021 and April 2022 after the vaccines were...

Full description

Bibliographic Details
Main Author:	Eyüp Dil
Format:	Article
Language:	English
Published:	Galenos Yayinevi 2023-09-01
Series:	Journal of Urological Surgery
Subjects:	andrology covid-19 infertility pfizer/biontech sinovac spermogram
Online Access:	http://jurolsurgery.org/archives/archive-detail/article-preview/effect-of-pfizer-biontech-and-sinovac-coronavac-va/62087

Similar Items

Impact of Pfizer-BioNTech COVID-19 Vaccination on the Menstrual Cycle
by: Harika Yumru Çeliksoy
Published: (2024-06-01)

Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
by: Dogan Mustafa, et al.
Published: (2023-06-01)

Erythematous reaction of the BCG site to Pfizer‐BioNTech COVID‐19 vaccine
by: Yuta Ito, et al.
Published: (2023-10-01)

Alergia a vacuna Pfizer-BioNTech demostrada mediante pruebas cutáneas.
by: Carlos David Estrada García, et al.
Published: (2023-01-01)

Humoral immunity against SARS-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile
by: Diego A. Díaz-Dinamarca, et al.
Published: (2023-08-01)

Evaluating Pharmacists’ Pharmacological Knowledge and Views Regarding Pfizer-BioNTech COVID-19 Vaccine in Saudi Arabia
by: Alorfi N, et al.
Published: (2022-04-01)

Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
by: Rami Alqassieh, et al.
Published: (2021-10-01)

Qualitative Assessment of Early Adverse Effects of Pfizer–BioNTech and Sinopharm COVID-19 Vaccines by Telephone Interviews
by: Sami Abu-Halaweh, et al.
Published: (2021-08-01)

Metabolic syndrome and the immunogenicity of Pfizer–BioNTech vaccine: a cross-sectional study in Japanese healthcare workers
by: Dong Van Hoang, et al.
Published: (2022-10-01)

Side Effects of Pfizer-BioNTech COVID-19 Vaccine among medical staff
by: Wail Sadeq, et al.
Published: (2022-12-01)

Eventos adversos por la vacuna COVID-19 Pfizer-BioNTech® en niños de 5-17años
by: María del Rocío Hernández-Morales, et al.
Published: (2024-12-01)

Exacerbation of immune thrombocytopenia following initial and booster vaccination with Pfizer-BioNTech COVID-19 vaccine
by: Maayan Aharoni, et al.
Published: (2022-07-01)

A Case of Acquired Aplastic Anemia after Severe Hepatitis- Probably Induced by the Pfizer/BioNTech Vaccine: A Case Report and Review of Literature
by: Zahra Kmira, et al.
Published: (2023-07-01)

Clinical outcomes of Pfizer‐BioNTech COVID‐19 vaccine in children and adolescents: A systematic review
by: Ahmad R. Al‐Qudimat, et al.
Published: (2022-07-01)

Gam-COVID-Vac (Sputnik V) and Pfizer-BioNTech Vaccines Adverse Events following Immunization in Patients Affected by Parkinson’s Disease and Multiple Sclerosis: A Longitudinal Study
by: Giorgia Soldà, et al.
Published: (2022-02-01)

A study on the side effects caused by the Pfizer/BioNTech COVID-19 vaccine: Focus on IgG antibodies and serological biomarkers
by: Kameran M. Ali, et al.
Published: (2024-04-01)

Delayed inflammatory reaction to hyaluronic acid lip filler after the Pfizer-BioNTech COVID-19 vaccine: A case report
by: Thikryat Neamatallah
Published: (2023-07-01)

COVID-19 Vaccine Take-up Rate, Safety and Tolerability in Patients with Epilepsy
by: Firdevs Ezgi Uçan Tokuç, et al.
Published: (2023-06-01)

SARS-CoV-2 Alpha Variant Infection of a Patient Immunized by Inactive Sinovac (CoronaVac) Vaccine
by: Ozverel Cenk Serhan, et al.
Published: (2022-01-01)

"Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)
by: Ahmed Samir, et al.
Published: (2023-03-01)

Exploring the adverse events of Oxford–AstraZeneca, Pfizer-BioNTech, Moderna, and Johnson and Johnson COVID-19 vaccination on Guillain–Barré Syndrome
by: Sultan Ayoub Meo, et al.
Published: (2024-08-01)

Comparison of antibody responses before and after booster doses with the Pfizer-BioNTech or Oxford–AstraZeneca vaccines in healthcare workers in Thailand
by: Uraporn Phumisantiphong, et al.
Published: (2023-04-01)

Side effects of Pfizer/BioNTech (BNT162b2) COVID-19 vaccine reported by the Birzeit University community
by: Abdallah Damin Abukhalil, et al.
Published: (2023-01-01)

Side Effects of COVID-19 Pfizer-BioNTech mRNA Vaccine in Children Aged 12–18 Years in Saudi Arabia
by: Edrous Alamer, et al.
Published: (2021-11-01)

The Effect of Age, Gender and Comorbidities Upon SARS-CoV-2 Spike Antibody Induction After Two Doses of Sinopharm Vaccine and the Effect of a Pfizer/BioNtech Booster Vaccine
by: Eman Farid, et al.
Published: (2022-05-01)

A racing heart post‐Pfizer/BioNTech BNT162b2
by: Hooi Khee Teo, et al.
Published: (2022-10-01)

Potential side effects after first and second doses of Pfizer-BioNTech COVID-19 vaccine in the United Arabia Emirates
by: Balsam Qubais Saeed, et al.
Published: (2023-01-01)

The Adverse Reactions of Pfizer BioNTech COVID-19 Vaccine Booster Dose are Mild and Similar to the Second Dose Responses: A Retrospective Cross-Sectional Study
by: El-Shitany NA, et al.
Published: (2022-08-01)

A Case of Concurrent Acute Macular Neuroretinopathy and Paracentral Acute Middle Maculopathy Following Pfizer-BioNTech COVID-19 Vaccination
by: Jale Menteş, et al.
Published: (2023-06-01)

Immune Response to CoronaVac and Its Safety in Patients with Type 2 Diabetes Compared with Healthcare Workers
by: Bothamai Dechates, et al.
Published: (2023-03-01)

Effectiveness of CoronaVac in preventing COVID-19 in healthcare workers
by: Gulsum Iclal Bayhan, et al.
Published: (2022-01-01)

BioNTech COVID-19 (BNT162b2) Vaccination and Varicella Zoster Reactivation: A Comprehensive Cross-sectional Study
by: Shir Azrielant, et al.
Published: (2024-02-01)

Effectiveness of Pfizer/BioNTech and Sinopharm COVID-19 vaccines in reducing hospital admissions in prince Hamza hospital, Jordan
by: Hafez Al-Momani, et al.
Published: (2022-09-01)

The Efficacy and Safety of Heterologous Immunization with Pfizer-BioNTech (Pfizer) to Individuals Who Have Completed A Primary Vaccination Schedule with Sinopharm (BBibp-CorV)
by: Nawfal R. Hussein, et al.
Published: (2023-09-01)

Adverse Effects of Pfizer (BioNTech), Oxford-AstraZeneca (ChAdOx1 CoV-19), and Moderna COVID-19 Vaccines among the Adult Population in Saudi Arabia: A Cross-Sectional Study
by: Jehad Aldali, et al.
Published: (2023-01-01)

Booster Vaccination with BNT162b2 Improves Cellular and Humoral Immune Response in the Pediatric Population Immunized with CoronaVac
by: Diego A. Díaz-Dinamarca, et al.
Published: (2024-08-01)

The subdued post-boost spike-directed secondary IgG antibody response in Ugandan recipients of the Pfizer-BioNTech BNT162b2 vaccine has implications for local vaccination policies
by: Violet Ankunda, et al.
Published: (2024-02-01)

Study of the Side Effects of Pfizer and Oxford COVID-19 Vaccines in the Eastern Province of Saudi Arabia
by: Farhat M, et al.
Published: (2022-09-01)

Humoral and Innate Immunological Profile of Paediatric Recipients of Pfizer-BioNTech BNT162b2 mRNA Vaccine
by: Sundararaj Stanleyraj Jeremiah, et al.
Published: (2024-07-01)

HEALTH-RELATED QUALITY OF LIFE POST-SINOVAC VACCINE IN COMMUNITIES IN TAMPAN DISTRICT AND MARPOYAN DISTRICT, PEKANBARU CITY
by: Seftika Sari, et al.
Published: (2023-03-01)